PMEF
GBIO

Point72 Middle East FZE’s Generation Bio GBIO Stock Holding History

Point72 Middle East FZE’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,934
Closed -$48.4K – 527
2023
Q4 		$48.4K Buy
+2,934
New +$51.2K ﹤0.01% 1287

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Point72 Middle East FZE's GBIO Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Generation Bio (GBIO) in Q1 2024, closing a stake of 2,934 shares — an estimated $48.4K sold.

Point72 Middle East FZE first reported a position in GBIO in Q4 2023 and held it in 1 quarter. The position peaked at $48.4K in Q4 2023. 74 funds tracked by Wall St. Rank hold GBIO as of Q1 2024.

  • Point72 Middle East FZE reported no remaining Generation Bio position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 2,934 Generation Bio shares in Q1 2024, an estimated $48.4K.
  • Point72 Middle East FZE first reported a position in Generation Bio in Q4 2023 and held it in 1 quarter.
  • Point72 Middle East FZE's Generation Bio position peaked at $48.4K in Q4 2023.
  • 74 funds tracked by Wall St. Rank held Generation Bio as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.